openPR Logo
Press release

Global Olmesartan Medoxomil (CAS 144689-63-4) Market Outlook 2016-2021

01-19-2017 07:30 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ReportBazzar

Global Olmesartan Medoxomil (CAS 144689-63-4) Market Outlook

Olmesartan medoxomil, the medoxomil ester of olmesartan, is novel and oral antagonist of angiotensin II TYPE-1 receptor (AT1 receptor) with an inhibition constant IC50 of 33 nmol/L. Through oral administration, olmesartan medoxomil is rapidly absorbed by the gastrointestinal tract converting to its active metabolite olmesartan, whose inhibition constant IC50 towards AT1 receptor is 8 nmol/L. The esterification of olmesartan with medoxomil moiety is just to improve its water solubility (from 4.5% to 28.6%). Olmesartan medoxomil is used for the treatment of hypertension, in which olmesartan dose-dependently reduces the blood pressure through arterial vasodilation and reducing sodium retention.

Request Sample Report Here:

This report provides detailed analysis of worldwide markets for Olmesartan Medoxomil (CAS 144689-63-4) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Olmesartan Medoxomil (CAS 144689-63-4) market and further lays out an analysis of the factors influencing the supply/demand for Olmesartan Medoxomil (CAS 144689-63-4), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC’s report, Global Olmesartan Medoxomil (CAS 144689-63-4) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Olmesartan Medoxomil (CAS 144689-63-4) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Olmesartan Medoxomil (CAS 144689-63-4) market are Daiichi Sankyo (Japan), Taj Pharmaceuticals (India), Divis Laboratories (India), Amoli Organics (India),Lupin (India), Zhejiang Tianyu (China), Zhuhai Rundu (China), Lianyungang Runzhong (China), HEC (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Olmesartan Medoxomil (CAS 144689-63-4) industry has been provided.

Browse Report Summary with TOC:

Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered

Part 2. Introduction
2.1 Definition
2.2 Current Scenario
2.2 Future Scenario

Part.3 Value Chain Analysis
3.1 Upstream
3.2 Downstream

Part 4. Manufacture
4.1 Manufacturing Process
4.2 Issues and Trends
4.3 Manufacturing Costs

Part 5. Worldwide Key Vendors
5.1 Company A
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Company B
5.3 Company C
5.4 Company D
5.5 Company E
5.6 Company F
5.7 Company G
5.8 Company H
5.9 Company I
5.10 Company J

Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 North America
6.2.2 EMEA
6.2.3 Asia-Pacific
6.2.4 ROW

Enquiry Before Buying:

About Us: is your trusted source for the most inclusive and informative assortment of market research reports designed to empower you with the latest in industry information that translates to time and cost savings for your business. We not only help you give wing to your latent business ideas but also facilitate you in taking the best informed and strategic decisions that guarantee success in your most promising business endeavors.

Contact Us:
Mary Jane
30 Wall Street, 8th floor,
New York, NY 10005.
US: +1 (212) 389-6363
India: +91 20 66528525
Email Id:

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Olmesartan Medoxomil (CAS 144689-63-4) Market Outlook 2016-2021 here

News-ID: 416473 • Views: 299

More Releases from ReportBazzar

Global Plasma Protein Therapeutic Industry Market Analysis & Forecast 2018-2023
Global Plasma Protein Therapeutic Industry Market Analysis & Forecast 2018-2023, the revenue is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023. The production is estimated at XX million in 2017 and is forecasted to reach XX million by the end of 2023, growing at a CAGR of XX%
Developments and Opportunities for Facial Recognition Technology in the Smart Re …
Facial recognition technology has been commercialized since the late 1990s. However, it did not quite get the attention it deserved until the September 11 attacks. Since then, market demand for advanced human-machine interaction interfaces soared in national security and personal property security in light of the rising awareness on anti-terrorism, the change in economic activities from traditional offline transactions to e-commerce and the lifestyle evolution which now craves for smart
Floating Solar Panels Market Research Report – Forecast to 2023
Global floating solar panels market is set to foresee significant growth in the upcoming years. Floating solar panels is a sophisticated technology developed for overcoming issues associated with conventional panels, such as high maintenance cost, land scarcity, etc. These panels are poised to gain traction over the next couple of years owing to its mobility and flexibility according to the sun’s position. The rapid exhaustion of fossil fuel has intensified the
Healthcare cold chain logistics Market Research Report – Forecast to 2023
The healthcare cold chain logistics market is one with a lot of promise largely due to the rapid growth of the healthcare and pharmaceutical sectors. With healthcare becoming a global focus, and intensive research & development activities being carried out by leading market players has significantly increased the demand for biopharmaceuticals and vaccines. These products traditionally, and presently require storage to ensure appropriate shelf life. Personalized medicine is an up

All 5 Releases

More Releases for Olmesartan

Olmesartan Market Size, Share & Growth Analysis To 2027| Daiichi Sankyo Company, …
Olmesartan, sold under the trade name Benicar among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease. It is a reasonable initial treatment for high blood pressure. Versions are available as the combination olmesartan/hydrochlorothiazide and olmesartan/amlodipine. Common side effects include dizziness, headaches, diarrhea, and back pain. Serious side effects may include kidney problems, low blood pressure, and angioedema. Use in pregnancy may harm the
Olmesartan Market 2020 Manufacturer Analysis, Emerging Trends, Top Companies and …
A comprehensive overview of the Olmesartan Market is recently added by Market Research Intellect to its humongous database. Furthermore, the Olmesartan Market report has been aggregated by collecting informative data of various dynamics such as market drivers, restraints, and opportunities. Furthermore, this innovative report makes use of SWOT, PESTLE, and Porter's Five Forces analyses to get a closer outlook on the Olmesartan Market. Furthermore, the Olmesartan Market report offers a
Olmesartan Market Research Report 2018 - 2023: Top Key Players Helios, Generic, …
The Study Paper in this Global Olmesartan Market includes: Unichem, Zydus Cadila, Bejing Winsunny Harmony, Mylan, Helios, Generic, CEPiA, Ranbaxy Laboratories Limited, Cipla, Knoll, Daiichi Sankyo Company, Glenmark. Get Free Sample Brochure of Olmesartan Market spread across [138 pages], profiling 13 companies and supported with tables and figures is now available at @ New Study on “2018 Market Research Report on Global Olmesartan Market
Global Olmesartan Market 2017 Key Players : Daiichi Sankyo Company, Zydus Cadila …
Qyresearchreports include new market research report "Global Olmesartan Sales Market Report 2017" to its huge collection of research reports. The global Olmesartan market will be extensively covered in our latest report, which mainly outlines key occurrences in the market. Product launches, advancements in technology, and collaborations within businesses are some of these events, which are exhaustively covered in the report. The study has been carried out based on qualitative as well
Global Olmesartan Medoxomil Sales Market Report 2017 Size, Analysis, Growth & Ov …
Qyresearchreports include new market research report "Global Olmesartan Medoxomil Sales Market Report 2017" to its huge collection of research reports. The investigation report here talks around a couple of points of view having a place with the overall Olmesartan Medoxomil publicize which verbalizes the present-day information and future discoveries with reference to the dynamic forces at play. The prime purpose of the investigation report is to offer the supporter with a
Global Olmesartan Medoxomil Industry Situation and Prospects Research Report and …
Market Research Hub (MRH) has recently published a latest market study to its online portal, which is titled as “Global Olmesartan Medoxomil Industry Situation and Prospects Research report”. The Global Olmesartan Medoxomil Industry Situation and Prospects Research report is a professional and in-depth study on the current state of the Olmesartan Medoxomil industry. Request Free Sample Report@ In 2016, the world economy expanded by just 2.2 per cent, the slowest rate